COMMUNIQUÉS West-GlobeNewswire

Eyenovia Announces Closing of $27.3 Million Initial Public Offering

29/01/2018 - 22:05

NEW YORK, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”), (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print [...]

Amarin Announces Proposed Public Offering of American Depositary Shares

29/01/2018 - 22:01

BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ) today announced a registered underwritten public offering of its American Depositary Shares. All of the [...]

Albireo Announces Closing of $74.8 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares

29/01/2018 - 22:01

BOSTON, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the completion of its [...]

Iovance Biotherapeutics, Inc. Announces Closing of $172.5 Million Common Stock Public Offering

29/01/2018 - 22:01

SAN CARLOS, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme

29/01/2018 - 22:00

CHARLOTTESVILLE, Va., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]

Misonix to Report Fiscal 2018 Second Quarter Financial Results, Host Conference Call and Webcast on February 6

29/01/2018 - 19:40

FARMINGDALE, N.Y., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]

Players Network, Inc. Selects 1-800-PublicRelations (1800pr) as Public Relations Agency of Record

29/01/2018 - 19:39

LAS VEGAS, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Players Network Inc. (OTCQB:PNTV), a diversified holding company operating in marijuana and media, announced today that 1-800-PublicRelations, Inc. ( 1800pr ) will serve as [...]

GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 5 February, 2018

29/01/2018 - 19:00

LONDON, Jan. 29, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]

Diaxonhit - Chiffre d'affaires 2017 à 42,9 M€, en très forte progression de 55%

29/01/2018 - 18:48

Chiffre d'affaires 2017 à 42,9 M€, en très forte progression de 55% Chiffre d'affaires pro forma à 48,0 M€ en progression de 9% Paris, le 29 janvier 2018 - Diaxonhit (FR0013240934, ALEHT, éligible PEA-PME), groupe [...]

OnePoint Patient Care Launches OneConnectPoint

29/01/2018 - 18:35

MORTON GROVE, Ill., Jan. 29, 2018 (GLOBE NEWSWIRE) -- OnePoint Patient Care has introduced OneConnectPoint, the hospice industry’s most advanced medication management application. Specifically designed to meet the [...]

IBA SA : Transparence notification

29/01/2018 - 18:00

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, January 29, 2018, 17.35 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]

IBA SA : Notification de transparence

29/01/2018 - 18:00

IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 29 janvier 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]

Sanofi: Disclosure of trading in own shares

29/01/2018 - 17:46

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/6e41672b-0d81-4b18-9200-48dfaee5babb

Sanofi : Déclaration des transactions sur actions propres

29/01/2018 - 17:46

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/c8d27e2e-859c-40f7-9b2c-ea4b2c7d0c71

Capital increase of 11,380 shares (equivalent to approximately 0.06% of the existing shares) in Orphazyme A/S as a result of an issue of bonus shares to KLSDC and UCLB

29/01/2018 - 17:29

Company announcement Orphazyme A/S No. 02/2018 Copenhagen, Denmark, January 29, 2018 – Orphazyme A/S, a Danish biotech company listed on Nasdaq Copenhagen (TICKER: ORPHA.CO), with a late-stage, orphan-drug pipeline, [...]

Pressure BioSciences, Inc. CEO, Ric Schumacher, Rejoins “Stock Day”, Very Optimistic About His Company’s Growth and Success in 2018 and Beyond

29/01/2018 - 17:09

PHOENIX, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Mr. Richard T. Schumacher, CEO and President of Pressure BioSciences, Inc. (OTCQB:PBIO) (the “Company”) returns to the “Stock Day” podcast for the first time since the Company’ [...]

ProCare Pain Solutions Publishes New Research Exploring Effects of Fibromyalgia on Chronic Pain Population

29/01/2018 - 17:04

MELVILLE, N.Y., Jan. 29, 2018 (GLOBE NEWSWIRE) -- ProCare Pain Solutions , a division of North American Partners in Anesthesia (NAPA) announced today that an innovative research study it conducted in 2016 and 2017 has [...]

Ossur Hf : Transactions in relation to share buyback program

29/01/2018 - 17:01

Announcement from Össur hf. No. 6/2018 Reykjavík, 29 January 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Forward Pharma Announces the Decision of the European Patent Office in the Opposition Proceedings for the EP2801355 Patent

29/01/2018 - 16:44

COPENHAGEN, Denmark, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (“Forward” or the “Company”) today announced that the European Patent Office (the “EPO”) has revoked the EP2801355 patent (the “’ [...]